By NewsDesk  @infectiousdiseasenews A new CDC study adds to the growing body of real-world evidence (outside of a clinical trial setting) showing that COVID-19 mRNA vaccines authorized by the Food and...

In a world-first, Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria. Lead researcher Professor...

By NewsDesk  @infectiousdiseasenews A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected...

By NewsDesk  @infectiousdiseasenews Following the initial reports of rare side effects after vaccination with the AstraZeneca vaccine (Vaxevria), a registry study was initiated quickly. The study includes...

More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research from the...

By NewsDesk  @infectiousdiseasenews On Wednesday, Connecticut Governor Ned Lamont  signed into law legislation that updates Connecticut’s immunization requirements for students attending preK-12...

By NewsDesk  @infectiousdiseasenews The  Finnish Institute for Health and Welfare (THL) will consider the inclusion of the Johnson & Johnson coronavirus vaccine in the Finnish vaccine programme...

Both mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) authorized and recommended in the United States protect against COVID-19-related hospitalization among adults 65 years and older, according to...

By NewsDesk  @infectiousdiseasenews The Swedish Public Health Agency has decided that Janssen’s vaccine, just like AstraZeneca’s vaccine, should only be recommended for people born in 1956...

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson...